Bayer AG’s pharmaceuticals unit is on track for a return to growth as new drugs for cancer and kidney disease offset sales lost to patent expirations.

India's Tagros has acquired Bayer AG's Flubendiamide business assets, gaining access to over 25 countries. This strengthens Tagros' position in the Diamide insecticide segment, supporting Indian and ...

The US Supreme Court agreed to hear Bayer AG’s appeal taking aim at thousands of lawsuits targeting its top-selling Roundup ...

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

The US Supreme Court agreed on Friday to hear Bayer’s bid to sharply limit lawsuits claiming that the company’s Roundup ...

As Northern European growers face plant disease and tightening regulations, Bayer launches a new strawberry to meet those ...

Bayer said on Tuesday that weak agricultural markets mean its earnings are likely to fall further next year, sparking a sharp fall in the German company’s shares and piling pressure on its CEO to ...

By Patricia Weiss BERLIN, Jan 13 (Reuters) - The pharmaceuticals and agriculture group Bayer aims to return its pharmaceuticals business to mid-single-digit percentage growth by no later than 2027 and ...

Good afternoon, and good morning, everybody, and welcome to our conference call for the third quarter of 2024. Bill will kick off our presentation today by sharing his perspective on business ...

Bayer AG forecast a third straight year of falling profit as the German company struggles with mass litigation in the US, slumping prices for agriculture products and fresh competition for one of its ...

The Supreme Court will hear Monsanto Company v. Durnell. The plaintiff alleges the weedkiller, Roundup, caused cancer.